Surmodics | SRDX - 贸易债权人

金融业

USD

USD 178.56M

现金及等价物

USD 36.12M

USD 33.03M

USD 81.3M

USD 20.54M

USD 29.55M

股息收益率

0

USD -322K

USD 1.53M

376

EPS每股收益

USD -0.25

股本和储备

USD 118.9M

USD -11.54M

债务利息支出

USD 884K

USD 29.55M

USD 393.5M

USD -11.54M

USD -245.35M

USD -5.65M

普通股股本

USD 716K

386.18

USD -7.51M

USD 29.92M

销售和管理费用

USD 14.58M

USD 15.17M

贸易债权人

USD 2.79M

应收帐款人

USD 23.27M

	贸易债权人	更改		日
Abbott	USD 4.12B		183M	2025-09
Align Technology	USD 121.45M		4.1M	2025-12
Anika Therapeutics	USD 4.73M		39K	2025-09
Arrowhead Research	USD 32.94M		15.26M	2025-12
Artivion	USD 16.5M		2.93M	2025-09
Baxter International	USD 999M		46M	2025-12
Boston Scientific	USD 1.14B		142M	2025-12
EDAP TMS	EUR 16.84M		1.7M	2025-09
Edwards Lifesciences	USD 165M		94.2M	2025-09
Haemonetics	USD 48.69M		13M	2025-12
Heron Therapeutics	USD 12.02M		20K	2025-09
J&J	USD 11.99B		2.37B	2025-12
Merit Medical Systems	USD 60.55M		4.19M	2025-12
Mesa Laboratories	USD 5.25M		163K	2025-12
Nektar Therapeutics	USD 15.56M		1.28M	2025-09
Option Care Health	USD 639.83M		11.96M	2025-12
Stryker	USD 1.5B		56M	2025-09
Surmodics	USD 2.79M		400K	2024-09
Trinity Biotech	USD 30.36M		3.87M	2025-09